Comparison of Left Ventricular Ejection Fraction Values from Equilibrium Radionuclide Angiocardiography between Planar and SPECT Techniques in Breast Cancer Patients
Main Article Content
Abstract
Background: Breast cancer patients receiving anthracycline-based chemotherapy are at risk of cardiotoxicity, which may lead to heart failure. Assessing the left ventricular ejection fraction (LVEF) is critical prior to each chemotherapy cycle. Equilibrium radionuclide angiocardiography is a noninvasive imaging technique commonly used for cardiac function evaluation. However, planar imaging may be affected by interference from adjacent tissues, particularly in patients with left-sided breast tumors or postoperative inflammation. SPECT imaging offers a three-dimensional approach that may improve accuracy by minimizing such interference. This study aims to compare the LVEF values obtained from planar and SPECT techniques.
Objective: To compare LVEF values between planar and SPECT imaging techniques in breast cancer patients undergoing nuclear cardiology evaluation.
Methods: A retrospective study was conducted with 160 breast cancer patients who underwent equilibrium radionuclide angiocardiography using 99mTc-RBC radiopharmaceuticals and were imaged with both planar and SPECT techniques on a SPECT/CT scanner. LVEF values of planar and SPECT images were analyzed using Syngo.Via™ and QBS software, respectively. The Wilcoxon Signed-Rank test was used to compare LVEF values, and Pearson’s correlation was employed to assess their relationship.
Results: The mean LVEF from planar imaging was 66.7 ± 6.7%, while that from SPECT was 74.4 ± 9.2%. The difference was statistically significant (p < 0.001), with a strong positive correlation between the two techniques (r = 0.645, p < 0.001).
Conclusion: SPECT imaging yields significantly higher and potentially more accurate LVEF values than planar imaging, particularly in patients where anatomical interference may impact planar results. SPECT should be considered a preferable method for cardiac assessment in breast cancer patients and may serve as a new standard in equilibrium radionuclide angiocardiography.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Perez IE, Taveras Alam S, Hernandez GA, Sancassani R. Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician. Clin Med Insights Cardiol 2019;13:1179546819866445. doi: 10.1177/1179546819866445.
Kolla BC, Roy SS, Duval S, Weisdorf D, Valeti U, Blaes A. Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends. Anticancer Res 2017;37(5):2445-9. doi: 10.21873/anticanres.11584.
Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90(1):29-34. doi: 10.1016/s0002-9149(02)02381-0.
Pennell DJ. Cardiovascular magnetic resonance. Circulation 2010;121(5):692-705. doi: 10.1161/CIRCULATIONAHA.108.811547.
Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010;55(23):2614-62. doi: 10.1016/j.jacc.2009.11.011.
Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000;21(16):1387-96. doi: 10.1053/euhj.2000.2011.
van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996;77(10):843-50. doi: 10.1016/s0002-9149(97)89179-5.
Pelletier-Galarneau M, Finnerty V, Tan S, Authier S, Gregoire J, Harel F. Assessment of left ventricular ejection fraction with cardiofocal collimators: Comparison between IQ-SPECT, planar equilibrium radionuclide angiography, and cardiac magnetic resonance. J Nucl Cardiol 2019;26(6):1857-64. doi: 10.1007/s12350-018-1251-6.
Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging 2008;35(4):851-85. doi: 10.1007/s00259-007-0694-9.
Krejcie RV, Morgan DW. Determining sample sizes for research activities. Educ Psychol Meas 1970;30:607-610.
นนทาชา ศิริทรานนท์, แสงจันทร์ เกษนาวา, ภัคภร พุทธนิยม, ฉัตรชัย นาวิกชีวิน, สุภัทรพร เทพมงคล. การศึกษาเปรียบเทียบสัดส่วนการบีบเลือดออกจากหัวใจห้องล่างซ้ายด้วยวิธีการทำสแกนแบบภาพตัดขวางสามมิติและแบบมูกา. วารสารรังสีเทคนิค 2566;48(1):71-8.
De Bondt P, De Winter O, De Sutter J, Dierckx RA. Agreement between four available algorithms to evaluate global systolic left and right ventricular function from tomographic radionuclide ventriculography and comparison with planar imaging. Nucl Med Commun 2005;26(4):351-9. doi: 10.1097/00006231-200504000-00008.
Martin RJ, Santiago B. Left Ventricular Function Parameters in a Hispanic Population: Comparison of Planar & Tomographic Radionuclide Ventriculography (MUGA). P R Health Sci J 2015;34(3):155-8. PMID: 26356740.
Groch MW, DePuey EG, Belzberg AC, Erwin WD, Kamran M, Barnett CA, et al. Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study. J Nucl Med 2001;42(12):1773-9. PMID: 11752072.
Chin BB, Bloomgarden DC, Xia W, Kim HJ, Fayad ZA, Ferrari VA, et al. Right and left ventricular volume and ejection fraction by tomographic gated blood-pool scintigraphy. J Nucl Med 1997;38(6):942-8. PMID: 9189147.
Huang H, Nijjar PS, Misialek JR, Blaes A, Derrico NP, Kazmirczak F, et al.Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2017;19(1):34. doi: 10.1186/s12968-017-0348-4.